Perioperative Risks and Outcomes in Asian American Patients with Type 2 Diabetes Mellitus and/or Metabolic Syndrome

A Systematic Scoping Review

Dados Bibliográficos

ID16928331
AutoresCatherine P Marudo (0000-0002-8862-041X, University of Miami), Vikasni Mohan (0009-0004-7946-3266, University of Miami), Sanjukta Dutta (University of Miami), J M Reynolds (0000-0001-6744-3517, University of Miami), Aisha Khan (0000-0001-5344-1748, University of Miami), Sabrina N Taldone, Sabrina Taldone (0000-0003-0099-4669, University of Miami), Eugene S Fu (0000-0001-8239-2818, University of Miami, autor correspondente)
Ano2026
Volume13
Fascículo2
Páginas1417-1433
Data de publicação2026-04-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoJournal of Racial and Ethnic Health Disparities (JOURNAL)
Identificadores do periódicoISSN: 2196-8837 • E-ISSN: 2197-3792
EditoraSpringer Science and Business Media LLC (PUBLISHER)
DOI10.1007/s40615-025-02344-6
PMID40042794
OpenAlexW4408220808
IdiomaEN
Referências citadas39

Asian Americans (AA) have an increased risk of developing type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) compared to non-Hispanic White Americans, yet over half of AA patients with T2DM are underdiagnosed or untreated. Surgical stress, known to exacerbate hyperglycemia in T2DM, is also associated with increased morbidity and mortality. Thus, AA patients may be at elevated risk of experiencing poor outcomes following surgery. This review aims to summarize the available literature on the perioperative (defined as before, during, and after surgery) risk and outcomes of T2DM in AA surgical patients and identify specific knowledge gaps. A scoping review protocol was developed in accordance with PRISMA guidelines. Medline, Embase, Web of Science, Scopus, and Cochrane CENTRAL were comprehensively searched for publications without language or date limits on perioperative management of undiagnosed and diagnosed T2DM and/or MetS in AA. Inclusion criteria included full-text studies conducted in the United States (U.S.), specified AA with T2DM and/or MetS as a study population, and focused on perioperative considerations or clinical outcomes. Search results yielded 862 articles imported into Covidence for title, abstracts, full-text screening, and data extraction. Fifteen publications were identified for full review: 13 (86.6%) retrospective cohort study articles, 1 (6.6%) review article, and 1 (6.6%) randomized controlled trial. These articles represented 2,494,987 total patients and 38,440 aggregate Asian American patients (1.5%). Notable findings amongst studies included (1) higher T2DM rates among AA compared to other racial/ethnic groups, (2) diagnosis variations among AA ethnic subgroups, (3) and conflicting findings on postoperative complications in AA. This review highlights knowledge gaps in our current understanding of disparities regarding perioperative risks and outcomes of AA surgical patients with T2DM and/or MetS. There is a need for stronger research methodologies to guide evidence-based recommendations regarding the perioperative risks and optimal management of this patient population

Diabetes mellitus · Intensive care medicine · MEDLINE · Metabolic syndrome · Pathology · Perioperative · Political science · Public health · Quality of Life Research · Type 2 Diabetes Mellitus · Bariatric Surgery and Outcomes · Cardiac, Anesthesia and Surgical Outcomes · Hyperglycemia and glycemic control in critically ill and hospitalized patients · Medicine · Endocrinology · Epidemiology · Internal Medicine · Surgery